Airware Labs Corp. Bundle
Who Really Controls Airware Labs Corp.?
Understanding the Airware Labs Corp. SWOT Analysis is crucial, but who truly steers the ship? The ownership structure of Airware Labs Corp. is a key determinant of its future, especially given its evolving strategic focus from medical devices to potentially other ventures. This analysis dives deep into the company's ownership journey, revealing the influences of key investors and significant shifts in its corporate identity.
From its inception as Crown Dynamics Corp. to its current form, Airware Labs Corp. has navigated a dynamic landscape. This exploration aims to uncover the
Who Founded Airware Labs Corp.?
Understanding the early ownership of Airware Labs Corp. (formerly Crown Dynamics Corp.) is crucial for grasping its corporate evolution. The company's history is marked by a significant acquisition that reshaped its ownership structure. This early phase sets the stage for understanding the current Airware Labs Corp. ownership and its trajectory.
Airware Labs Corp. originated as Crown Dynamics Corp., incorporated in Delaware on June 15, 2010. The company's path involved a strategic move to acquire Airware Holdings, Inc. This acquisition, finalized on March 20, 2012, was a reverse merger, with Airware Holdings, Inc. becoming the accounting acquirer. This maneuver effectively made Airware Holdings, Inc.'s financial history the foundation for the combined entity.
David Dolezal, a former President and Executive Chairman, played a key role, though he no longer holds any ownership. Early financial backing included a convertible secured bridge note from Stockbridge Enterprises, L.P., with a borrowing of $2,958,000 as of December 31, 2014. The initial focus of Airware Holdings, Inc. was on developing medical products, specifically nasal breathing devices.
Crown Dynamics Corp. Incorporation
Crown Dynamics Corp. was established on June 15, 2010, in Delaware, marking the initial legal foundation of what would become Airware Labs Corp.
Airware Holdings, Inc. Acquisition
The acquisition of Airware Holdings, Inc. on March 20, 2012, was a pivotal event, changing the company's direction and ownership dynamics.
Reverse Merger
The transaction was structured as a reverse merger, with Airware Holdings, Inc. as the accounting acquirer, influencing the company's financial reporting.
David Dolezal's Role
David Dolezal served as President and Executive Chairman but no longer holds ownership in the company.
Early Financial Backing
Stockbridge Enterprises, L.P., provided early financial support through a convertible secured bridge note.
Initial Business Focus
The original business plan centered on developing and distributing non-prescription medical products, specifically nasal breathing devices.
It's important to distinguish Airware Labs Corp. from another company named 'Airware, Inc.', founded in 2011 by Jonathan Downey. This other company focused on commercial unmanned aerial vehicles (UAVs) and ceased operations on September 14, 2018. This drone-focused 'Airware' raised $116 million over 10 rounds from 24 investors. For a broader perspective on the competitive landscape, consider reading about the Competitors Landscape of Airware Labs Corp.
Airware Labs Corp. SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Airware Labs Corp.’s Ownership Changed Over Time?
The evolution of Airware Labs Corp.'s ownership is marked by a pivotal shift in 2018. The company, initially focused on medical devices, transitioned significantly. This transformation was primarily driven by a reverse merger and subsequent name change, which redefined its business focus and, consequently, its ownership structure.
On March 21, 2018, Airware Labs Corp. acquired BSSD Group, LLC, operating as Item 9 Labs. This acquisition was a reverse merger, indicating a strategic pivot. Following the acquisition, on April 27, 2018, Airware Labs Corp. officially became Item 9 Labs Corp., changing its ticker symbol to 'INLB'. This restructuring fundamentally altered the company's direction towards the cannabis bio-medical industry. This strategic move likely attracted a new set of Airware Labs investors and stakeholders.
| Event | Date | Impact on Ownership |
|---|---|---|
| Acquisition of BSSD Group, LLC (Item 9 Labs) | March 21, 2018 | Reverse merger; shift to cannabis industry; change in Airware Labs shareholders. |
| Name Change to Item 9 Labs Corp. | April 27, 2018 | Formalized the shift; new identity; likely new Airware Labs investors. |
| Focus Shift | 2018 onwards | Transition from medical devices to cannabis-related solutions; new strategic direction. |
As of 2023, Item 9 Labs Corp. is focused on cannabis and related solutions, offering over 300 products. The company's ownership status is listed as 'Acquired/Merged,' and its financing status is 'Corporate Backed or Acquired.' While specific current major individual stakeholders are not publicly detailed in recent reports, the transition to a cannabis-focused entity implies a new set of investors and stakeholders aligned with this industry. The medical device market, where Airware Labs Corp. originally operated, was valued at approximately $542.21 billion in 2024, with projections to reach $572.31 billion in 2025. For further insights into the company's strategic positioning, consider reading the article on Target Market of Airware Labs Corp.
Key Ownership Changes
The acquisition of BSSD Group, LLC, and the subsequent name change marked a significant shift in Airware Labs Corp.'s ownership and business focus.
- Reverse merger with Item 9 Labs led to a new strategic direction.
- The company transitioned from medical devices to cannabis-related solutions.
- The shift likely brought in a new group of Airware Labs investors.
- The company's current operations are centered around cannabis products.
Airware Labs Corp. PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Airware Labs Corp.’s Board?
Due to the 2018 restructuring and name change of Airware Labs Corp. to Item 9 Labs Corp., current information about the board of directors and voting power focuses on Item 9 Labs Corp. rather than the original entity. Current details regarding individual board members or the specific voting structure (e.g., one-share-one-vote, dual-class shares) for Item 9 Labs Corp. are not readily available in publicly accessible 2024-2025 data.
However, historical context from the drone company, not the medical device company, indicates that previous board members included representatives from major venture capital firms. This illustrates how significant Airware Labs Corp. investors often gain board representation. The shift in focus and reverse mergers typically lead to changes in board composition, reflecting the interests of new shareholders and the company's new direction.
| Aspect | Details | Status |
|---|---|---|
| Board Composition | Information on current board members | Not publicly available (2024-2025) |
| Voting Structure | Details on voting rights (e.g., one-share-one-vote) | Not publicly available (2024-2025) |
| Historical Context | Former board members from the drone company | Included representatives from major venture capital firms |
While specific voting rights details are unavailable, companies in the cannabis industry generally follow standard corporate governance practices. Shareholder agreements or founder shares could potentially grant outsized control. There are no readily available reports from 2024-2025 detailing recent proxy battles or activist investor campaigns for Item 9 Labs Corp.
Ownership Insights
Understanding the board of directors and voting power is crucial for assessing Airware Labs Corp. ownership. The composition of the board often reflects the interests of major stakeholders. The voting structure determines the influence of different shareholder groups.
- Board composition reflects shareholder interests.
- Voting structure determines shareholder influence.
- Information on current board members is not publicly available.
- Details on the voting structure are not readily accessible.
Airware Labs Corp. Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Airware Labs Corp.’s Ownership Landscape?
The most significant recent development concerning Airware Labs Corp., now operating as Item 9 Labs Corp., is its complete transformation. This shift, which occurred in April 2018, involved a strategic pivot from its original focus on medical devices to the cannabis bio-medical industry. This change fundamentally altered the company's trajectory and, consequently, the nature of its ownership profile. Therefore, understanding Airware Labs Corp.'s current ownership requires looking at Item 9 Labs Corp., its successor, and its activities within the cannabis sector.
While Airware Labs Corp. no longer exists as a distinct entity, the broader medical device industry, where it initially operated, continues to evolve. The global medical devices market was valued at approximately $542.21 billion in 2024. Projections indicate substantial growth, with an expected value of $886.68 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.5% from 2025. The airway management devices market, a specific segment relevant to the original scope of Airware Labs Corp., is also experiencing growth. This market is projected to increase from $2.55 billion in 2024 to $2.61 billion in 2025, with an anticipated rise to $3.48 billion by 2029, demonstrating a CAGR of 7.4%.
| Metric | Value (2024) | Projected Value (2032) |
|---|---|---|
| Global Medical Devices Market | $542.21 billion | $886.68 billion |
| Airway Management Devices Market | $2.55 billion | $3.48 billion (by 2029) |
| CAGR (Global Medical Devices) | 6.5% (from 2025) | |
| CAGR (Airway Management Devices) | 7.4% (by 2029) |
As Item 9 Labs Corp., the focus is on the cannabis sector. The company has directed its efforts towards developing technology and products for administering medical marijuana through an intra-nasal delivery system. No public statements from 2024-2025 specifically address future ownership changes, planned succession, or potential privatization/public listing for Airware Labs Corp. as it is now Item 9 Labs Corp. To understand the company's operations better, you can also explore Revenue Streams & Business Model of Airware Labs Corp.
Airware Labs Corp.
Formerly focused on medical devices. Now operates as Item 9 Labs Corp.
Ownership Transition
The company's shift to the cannabis sector has redefined its ownership profile.
Industry Trends
Medical device industry is experiencing significant growth and consolidation.
Future Outlook
Item 9 Labs Corp. focuses on cannabis and related product development.
Airware Labs Corp. Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of Airware Labs Corp. Company?
- What is Competitive Landscape of Airware Labs Corp. Company?
- What is Growth Strategy and Future Prospects of Airware Labs Corp. Company?
- How Does Airware Labs Corp. Company Work?
- What is Sales and Marketing Strategy of Airware Labs Corp. Company?
- What is Brief History of Airware Labs Corp. Company?
- What is Customer Demographics and Target Market of Airware Labs Corp. Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.